Interleukin-18 Promoter Polymorphisms in Type 1 Diabetes
Authors:
- 1 November 2002
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 51 (11) , 3347-3349
Abstract
Type 1 diabetes is believed to be a Th1 lymphocyte–mediated disease, and both environmental and genetic factors play a role in its pathogenesis. It was recently found that interleukin (IL)-18 acts as a proinflammatory cytokine and, in synergy with IL-12, promotes development of Th1 lymphocyte response by induction of γ-interferon production. The aim of our study was to evaluate the frequency of known polymorphisms in the IL-18 promoter in patients with type 1 diabetes in comparison with healthy control subjects, since higher levels of IL-18 were recently reported in the subclinical stage of type 1 diabetes. We studied two recently described single-nucleotide polymorphisms of the promoter of IL-18 gene at the position −137 and −607, which have been suggested to cause differences in transcription factor binding and have an impact on IL-18 gene activity. The genotype distribution differed significantly between patients with type 1 diabetes and control subjects. The difference reflected an increase in the GC genotypes and a decrease in GG genotypes at position −137 in the promoter of IL-18 gene. AA genotype at position −607 was found only in the control group. The results also demonstrated that the contribution of −137GC genotypes to genetic susceptibility to type 1 diabetes differs depending on the combination of IL-18 promotor gene haplotypes. Our study suggests the first evidence of an association between type 1 diabetes and polymorphisms in the promoter of IL-18 gene.Keywords
This publication has 15 references indexed in Scilit:
- Functional IL-18 Is Produced by Primary Pancreatic Mouse Islets and NIT-1 Beta Cells and Participates in the Progression towards Destructive InsulitisHormone Research in Paediatrics, 2002
- Synergy of IL-12 and IL-18 for IFN-γ Gene Expression: IL-12-Induced STAT4 Contributes to IFN-γ Promoter Activation by Up-Regulating the Binding Activity of IL-18-Induced Activator Protein 1The Journal of Immunology, 2002
- The large increase in incidence of Type I diabetes mellitus in PolandDiabetologia, 2001
- Is childhood-onset Type I diabetes a wealth-related disease? An ecological analysis of European incidence ratesDiabetologia, 2001
- Serum levels of the interferon-γ-inducing cytokine interleukin-18 are increased in individuals at high risk of developing Type I diabetesDiabetologia, 2001
- Disease resistant, NOD-related strains reveal checkpoints of immunoregulation in the pancreasJournal of Molecular Medicine, 2001
- Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B alleleNature Genetics, 2001
- Cytokine secretion patterns in twins discordant for Type I diabetesDiabetologia, 1999
- Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2.Journal of Clinical Investigation, 1997
- A genome-wide search for human type 1 diabetes susceptibility genesNature, 1994